Maze Therapeutics counsel gets 11K RSU shares
Maze Therapeutics, Inc. (MAZE) reported that its General Counsel and Corporate Secretary, Courtney Phillips, exercised previously granted restricted stock units on September 1, 2026, receiving 11,000 shares of Common Stock through an RSU vesting event.
Rhea-AI Filing Summary
Maze Therapeutics, Inc. (MAZE) reported that its General Counsel and Corporate Secretary, Courtney Phillips, exercised previously granted restricted stock units on September 1, 2026, receiving 11,000 shares of Common Stock through an RSU vesting event.
The 11,000 RSUs, each representing a contingent right to one share of Common Stock, vested in connection with an award that vests as to one-half of the total award on September 1, 2026 and September 1, 2027, subject to continued service. These RSUs do not expire; they either vest or are cancelled prior to the vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
11,000 shares exercised/converted
Exercise
2 txns
Insider
Courtney Phillips
Role
GC and Corp. Secretary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F2, F3 | 11,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,000 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 11,000 contracts (Direct);
Common Stock — 11,000 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- F2. The award vested or vests as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date.
- F3. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.
Key Figures
RSUs exercised: 11,000 units
Common Stock acquired: 11,000 shares
Holdings after transaction: 11,000 shares
+2 more
5 metrics
RSUs exercised
11,000 units
Restricted Stock Units converted to Common Stock on September 1, 2026
Common Stock acquired
11,000 shares
Shares received by Courtney Phillips upon RSU settlement on September 1, 2026
Holdings after transaction
11,000 shares
Direct Common Stock holdings reported following the September 1, 2026 transaction
First vesting date
September 1, 2026
One-half of the RSU award vests on this date, subject to continued service
Second vesting date
September 1, 2027
Remaining one-half of the RSU award vests on this date, subject to continued service
Key Terms
Restricted Stock Units, contingent right, vested, cancelled prior to the vesting date
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"represents a contingent right to receive one share of the Issuer's Common Stock"
vested financial
"The award vested or vests as to 1/2 of the total award on September 1, 2026"
cancelled prior to the vesting date financial
"These restricted stock units do not expire; they either vest or are cancelled prior"
FAQ
What insider transaction did MAZE report for Courtney Phillips on September 1, 2026?
Maze Therapeutics reported that Courtney Phillips exercised 11,000 restricted stock units on September 1, 2026, receiving 11,000 shares of Common Stock through a derivative exercise/conversion related to an RSU award.
What position does Courtney Phillips hold at MAZE?
Courtney Phillips is reported as an officer of Maze Therapeutics, serving as General Counsel and Corporate Secretary, and filed this Form 4 in that capacity.
How many MAZE restricted stock units were involved in the September 1, 2026 transaction?
The transaction involved 11,000 restricted stock units, each representing a contingent right to receive one share of Maze Therapeutics’ Common Stock upon settlement.
What is the vesting schedule of the MAZE restricted stock unit award reported?
The award vests as to one-half of the total RSU award on September 1, 2026 and one-half on September 1, 2027, subject to Courtney Phillips’ continued service to Maze Therapeutics on each vesting date.
Do the MAZE restricted stock units reported have an expiration date?
The filing states that these restricted stock units do not expire; they either vest or are cancelled prior to the vesting date, rather than expiring on a set option expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
